Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NeoAdapt 3: An Observational Study Investigating Novel Biomarkers in the Evaluation and Treatment of Neonatal Circulatory Insufficiency in Infants Suffering From Hypoxic Ischemic Encephalopathy.

NCT02051894 is registered in ClinicalTrials.gov with Brighton and Sussex University Hospitals NHS Trust as lead sponsor.

NCT NCT02051894
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02051894 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NeoAdapt 3: An Observational Study Investigating Novel Biomarkers in the Evaluation and Treatment of Neonatal Circulatory Insufficiency in Infants Suffering From Hypoxic Ischemic Encephalopathy.
Lead sponsor
Brighton and Sussex University Hospitals NHS Trust
Phase
Observational
Overall status
Completed
Start date
September 30, 2014
Completion date
September 30, 2016
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

circulatory failure